Clinical trial
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in…
NCT00003270 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003270 |
|---|---|
| Title | Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer |
| Official title | Cord Blood Transplantation for Hematologic Malignancies and Bone Marrow Failure Syndromes |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | anti-thymocyte globulin, filgrastim, busulfan, cyclophosphamide, cyclosporine, methylprednisolone, bone marrow ablation with stem cell support, umbilical cord blood transplantation, radiation therapy |
| Enrollment | 20 |
| Start date | Sep 4, 1997 |
| Primary completion | Oct 16, 2017 |
| Completion | Oct 16, 2017 |
| First posted | Apr 27, 2004 |
| Last update posted | Dec 13, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: